What is the level of liabilities of Nkarta this year?
Nkarta has a debt balance of 105.6 M USD this year.
Nkarta Liabilities 2024
Nkarta Liabilities
105.6 M USD
Ticker
NKTX
ISIN
US65487U1088
WKN
A2P797
In 2024, Nkarta's total liabilities amounted to 105.6 M USD, a 4.87% difference from the 100.7 M USD total liabilities in the previous year.
Nkarta Aktienanalyse
What does Nkarta do?
Nkarta Inc is a biopharmaceutical company based in South San Francisco, California. The company was founded in 2015 by Dr. Raphael Rousseau (CEO) to develop a groundbreaking new therapy for cancer patients. The business model of Nkarta is based on the development of novel CAR-T cell therapies. These are a special type of immunotherapy in which the patient's own immune cells are genetically modified and used to target tumor cells. Unlike conventional chemotherapy or radiation, which can also attack healthy cells, CAR-T cell therapies specifically target cancer cells while sparing the surrounding healthy tissue. Nkarta is divided into various business areas, including research and development of new therapies, manufacturing and production of CAR-T cells, and clinical trials and approval processes for broad application. One of Nkarta's key products is NKR-2, a CAR-T cell therapy based on natural killer cells. These cells have high activity against cancer cells and can respond quickly to threats. NKR-2 differentiates itself from other therapies by its ability to be effective even at low concentrations. This means that fewer cells are needed and the risk of unwanted side effects is reduced. Nkarta is also working on other projects, including NKX101, which specializes in treating solid tumors, and Voretigene Neparvovec, a gene therapy for the rare hereditary retinal disease. In 2020, Nkarta entered into a partnership with CRISPR Therapeutics to explore the joint potential of CRISPR gene editing and CAR-T cell therapy. The collaboration aims to improve the precision and effectiveness of CAR-T cell therapies and ultimately increase the chances of a cure for cancer patients. Overall, Nkarta has had an impressive success story in recent years. The company has raised several million dollars in funding and continues to expand. The groundbreaking technology of CAR-T cell therapies is promising and has the potential to have a sustainable impact on healthcare. With Nkarta at the forefront, the future could look much more hopeful for cancer patients. Nkarta ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Nkarta's Liabilities
Nkarta's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Nkarta's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Nkarta's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Nkarta's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Nkarta’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Nkarta stock
What were the liabilities of Nkarta compared to the previous year?
The liabilities of Nkarta have increased by 4.87% increased compared to the previous year.
What are the consequences of high debt for investors of Nkarta?
High liabilities can pose a risk for investors of Nkarta, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Nkarta?
Low liabilities mean that Nkarta has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Nkarta affect the company?
An increase in liabilities of Nkarta can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Nkarta affect the company?
A decrease in the liabilities of Nkarta can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Nkarta?
Some factors that can influence the liabilities of Nkarta include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Nkarta so important for investors?
The liabilities of Nkarta are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Nkarta take to modify the liabilities?
To change its liabilities, Nkarta can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Nkarta pay?
Over the past 12 months, Nkarta paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nkarta is expected to pay a dividend of 0 USD.
What is the dividend yield of Nkarta?
The current dividend yield of Nkarta is .
When does Nkarta pay dividends?
Nkarta pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nkarta?
Nkarta paid dividends every year for the past 0 years.
What is the dividend of Nkarta?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nkarta located?
Nkarta is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nkarta kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nkarta from 12/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/5/2024.
When did Nkarta pay the last dividend?
The last dividend was paid out on 12/5/2024.
What was the dividend of Nkarta in the year 2023?
In the year 2023, Nkarta distributed 0 USD as dividends.
In which currency does Nkarta pay out the dividend?
The dividends of Nkarta are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Nkarta
Our stock analysis for Nkarta Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nkarta Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
